| 000 | 01659 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515110206.0 | ||
| 264 | 0 | _c20080702 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a0924-977X | ||
| 024 | 7 |
_a10.1016/j.euroneuro.2007.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuchs, Sabine A | |
| 245 | 0 | 0 |
_aCerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. _h[electronic resource] |
| 260 |
_bEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology _cMay 2008 |
||
| 300 |
_a333-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
| 650 | 0 | 4 |
_aGlycine _xcerebrospinal fluid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aSchizophrenia _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aSerine _xcerebrospinal fluid |
| 700 | 1 | _aDe Barse, Martina M J | |
| 700 | 1 | _aScheepers, Floor E | |
| 700 | 1 | _aCahn, Wiepke | |
| 700 | 1 | _aDorland, Lambertus | |
| 700 | 1 | _ade Sain-van der Velden, Monique G | |
| 700 | 1 | _aKlomp, Leo W J | |
| 700 | 1 | _aBerger, Ruud | |
| 700 | 1 | _aKahn, René S | |
| 700 | 1 | _ade Koning, Tom J | |
| 773 | 0 |
_tEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology _gvol. 18 _gno. 5 _gp. 333-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.euroneuro.2007.12.002 _zAvailable from publisher's website |
| 999 |
_c17767210 _d17767210 |
||